Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Operating Expenses | 5,960 | 9,680 | 10,970 | 9,190 | 9,080 |
| Operating Income | -5,960 | -9,680 | -10,970 | -9,190 | -9,080 |
| Interest Expense | 590 | 630 | 1,600 | 750 | 790 |
| Other Income | 10 | -1,570 | -600 | 70 | 150 |
| Pre-tax Income | -6,540 | -11,880 | -13,170 | -9,870 | -9,720 |
| Net Income Continuous | -6,546 | -11,889 | -13,168 | -9,877 | -9,720 |
| Net Income | $-6,546 | $-11,889 | $-13,168 | $-9,877 | $-9,720 |
| EPS Basic Total Ops | -5.60 | -11.60 | -14.40 | -11.60 | -11.20 |
| EPS Basic Continuous Ops | -5.51 | -10.99 | -14.27 | -11.36 | -11.20 |
| EPS Diluted Total Ops | -5.60 | -11.60 | -14.40 | -11.60 | -11.20 |
| EPS Diluted Continuous Ops | -5.51 | -10.99 | -14.27 | -11.36 | -11.20 |
| EBITDA(a) | $-5,230 | $-8,890 | $-10,190 | $-8,390 | $-8,220 |